Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study - Top-Institutions - MDSpire

Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study

  • By

  • Lukas Schaffarczyk

  • Patricia Carla Mayer

  • Axel Hamprecht

  • Philipp Thelen

  • May 18, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University Hospitals
    University Hospitals

    Cleveland, Ohio

    Key Differentiators

    • Infectious Disease

  • #2

    Institute for Medical Microbiology and Virology
    Institute for Medical Microbiology and Virology

    Oldenburg, Lower Saxony

    Key Differentiators

    • Microbiology
    • Infectious Disease

  • #3

    Oldenburg Medical Center
    Oldenburg Medical Center

    Oldenburg, Lower Saxony

    Key Differentiators

    • Infectious Disease

Original Source(s)

Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study

  • by Lukas Schaffarczyk, Patricia Carla Mayer, Axel Hamprecht, Philipp Thelen

  • May 18, 2026

Related Content

Artificial intelligence based predictive models for early sepsis detection in intensive care units: a scoping review

The prognostic value of the CALLY index in sepsis: a systematic review and meta-analysis

Diagnostic performance of interleukin-27 and C-reactive protein in neonatal sepsis: an updated systematic review and meta-analysis